In this article, we will be taking a look at the 10 Oversold Insurance Stocks to Buy According to Analysts.

A crucial shift from “hard market” volatility to a phase of tactical stability characterizes the $3.35 trillion US insurance market as it approaches 2026. The sector is going through a “soft landing,” with overall premium growth predicted to slow to about 4% in 2026, down from 5.5% in 2025, following several years of strong rate hikes. As return on equity (ROE) is expected to remain stable at 10%, supported by rising investment rates reaching an estimated 4.2%, the narrative for investors has evolved from pure price momentum to operational excellence.

The landscape remains bifurcated between property and casualty (P&C). Commercial property is finally offering relief to buyers, with rate reductions in early 2026 ranging from high single digits to more than 20% for well-protected risks. This shift is driven by a surge in market capacity, including several new domestic carriers and new syndicates at Lloyd’s entering the property space. Conversely, the casualty sector remains under pressure due to “social inflation.”

Nuclear verdicts, jury awards exceeding $10 million, have surged in both frequency and severity, with total payouts rising sharply in recent years and median verdicts now exceeding $50 million. These escalating loss-cost pressures are forcing insurers to maintain strict underwriting discipline in lines such as commercial auto and umbrella liability.

In terms of technology, the insurance business will transition from AI experimentation to widespread operational implementation in 2026. As carriers rapidly incorporate AI and automation into underwriting, claims administration, and customer support processes, industry technology investment is expected to reach over $173 billion in 2026, or roughly 7.8% growth. Leading insurers are integrating sophisticated and agentic AI capabilities into their fundamental business processes; among the biggest carriers, automation is predicted to increase expense ratios by about two percentage points. In the meantime, there are specific challenges facing the health insurance industry.

ACA Marketplace rates are expected to increase by a median of almost 18% in 2026 due to increased healthcare consumption, rising medical expenditures, and the expanding use of pricey specialty pharmaceuticals like GLP-1 diabetic and weight-loss pills. The 2026 market offers a mixed picture for strategic investors, with declining property insurance rates coexisting with ongoing liability and healthcare cost pressures.

With that said, let’s now move on to the most oversold stocks.

Our Methodology

For our methodology, we used screeners to identify stocks with an RSI reading of less than 40, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

Here is our list of the 10 oversold insurance stocks to buy according to analysts.

10. Aegon Ltd. (NYSE:AEG)

Aegon Ltd. (NYSE:AEG) is one of the oversold stocks on our list.

TheFly reported on March 5 that Citi increased its price target on AEG to EUR 8.02, up from EUR 7.69, while reiterating a Buy rating on the stock.

Separately, Aegon Ltd. (NYSE:AEG) said on March 10 that it has recently increased its footprint in China by establishing Aegon Insurance Asset Management Company (Aegon IAMC), a Shanghai-based, wholly owned insurance asset management company. After completing operational and regulatory preparations and obtaining its insurance asset management license in June 2025, the firm started operations on February 2, 2026.

The launch enables AEG to directly access long-term investment opportunities in China that typically require a dedicated insurance asset management license. These opportunities include investments across sectors such as infrastructure, renewable energy, and other long-duration assets that align with the insurer’s long-term investment strategy and asset-liability management objectives.

Additionally, earlier on February 19, Aegon reported that in 2H 2025, its net result stood at €375 million, which is down from €741 million in 2H 2024 due to non-operating items, while the full-year net result rose 45% to €980 million. Operating results increased 11% in 2H to €858 million and 15% for the year to €1.7 billion, supported by all business units and favorable markets. The corporation’s Valuation equity rose 7% to €9.06 per share. Capital generation reached €711 million in 2H and €1.3 billion full-year, with strong ratios, €388 million free cash flow, and a proposed €0.21 final dividend

Aegon Ltd. (NYSE:AEG)is an international financial services company providing life insurance, pensions, retirement, and asset management products to individuals and businesses worldwide.

9. eHealth, Inc. (NASDAQ:EHTH)

eHealth, Inc. (NASDAQ:EHTH) is one of the most oversold insurance stocks on this list.

TheFly reported on March 11 that EHTH saw its price target reduced by RBC Capital to $3 from $9, while the firm reiterated a Sector Perform rating on the stock. Despite the company’s strong fourth-quarter results, the outlook was negatively impacted by lower-than-expected 2026 revenue expectations. The firm claims that conservative forecasts for the next annual enrollment cycle and a major Medicare Advantage insurer’s lower marketing investment are the main causes of the softer forecast.

On February 25, 2026, eHealth, Inc. (NASDAQ:EHTH) released its financial results for the fourth quarter and the entire year that ended on December 31, 2025. The company’s Medicare sector performed better than expected, contributing to a 4% year-over-year rise in quarterly sales of $326.2 million. Revenue increased to $554 million for the entire fiscal year, which is likewise a 4% increase over 2024.

The corporation’s GAAP net income for the fourth quarter fell to $87.2 million from $97.5 million a year earlier despite strong top-line growth, mostly as a result of a higher effective tax rate. But because to improved Medicare unit economics and cost control initiatives, adjusted EBITDA increased 10% to $132.9 million.

For 2026, the business projected total revenue between $405 million and $445 million, alongside continued initiatives aimed at improving efficiency and profitability.

eHealth, Inc. (NASDAQ:EHTH) operates an online marketplace that helps consumers compare and enroll in Medicare and individual health insurance plans from multiple carriers across the United States.